Revance Therapeutics (RVNC) stock drops 5.6% as Crown Laboratories fails to start tender offer by deadline, impacting acquisition agreement.
https://seekingalpha.com/news/4150022-revance-therapeutics-falls-as-crown-labs-didnt-start-tender-offer-by-deadline
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.